Home » Newsletters » BioWorld Science

BioWorld Science

June 2, 2004

View Archived Issues

AOP and Lantibio enter licensing agreement for Moli-1901

Allergan and Kyorin sign Japanese agreement for Alphagan franchise

Concurrent to acquire Allergan retinoid portfolio

LeuTech to be renamed NeutroSpec

Praecis updates Plenaxis progress and highlights clinical program developments

PG-490-88 prolongs survival in renal allograft models

Farnesyltransferase inhibitor delays development of acute rejection

JAK-3 inhibition prevents obliterative bronchiolitis after tracheal transplantation

Preclinical milestone reached in Neurogen/Merck & Co pain alliance

Metvix launch under way in Australia

Six months additional exclusivity for Agrylin

European MAA submitted for liquid Aricept

New ATS guidelines recommend use of tiotropium for COPD

Biotronik enters distribution deal for Conor Medsystems' Costar stent

Xanodyne launches hycet

Yamanouchi and Pfizer restructure Japan partnership

Termination of Genasense Expanded Access Program

Myriad Genetics achieves significant progress on many fronts during third quarter

BioMarin highlights first quarter developments

Clinical efficacy of an olmesartan medoxomil/hydrochlorothiazide combination in hypertension

PGN-0052 induces bronchodilatation in patients with mild to moderate asthma

EPI-12323 reduces the severity of late allergic reactions in asthmatics

Therapeutic benefits found with ambrisentan in PAH

UCB-35440-3 relieves bronchoconstriction in vivo

Preclinical results on activity of OPC-6535 in COPD

Nebulized doripenem effective in P. aeruginosa pneumonia model

Merck KGaA presents bispecific anti-ErbB antibodies for cancer therapy

Scios researchers describe new p38alpha inhibitors

Novel 5-HT6 receptor ligands identified by Roche scientists

Elan patent covers new bradykinin antagonists for pain and other uses

New cannabinoid CB1 antagonists in early development at Pfizer

New FAAH inhibitors with potential utility as analgesic agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...